Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler , President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 C
|
CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 Conference, which takes place virtually January 11 – 14, 2021.
The recorded presentation will be available on the Investors section of the Company’s website at https://ir.akebia.com beginning Monday, January 11. About Akebia Therapeutics Akebia Therapeutics Contact
SOURCE Akebia Therapeutics | ||
Company Codes: NASDAQ-NMS:AKBA |
View original content to download multimedia:
